Ksenija Rener-Sitar1, Mike T John2, Snigdha S Pusalavidyasagar3, Dipankar Bandyopadhyay4, Eric L Schiffman2. 1. Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN, USA; Department of Prosthodontics, Dental Division, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; University Dental Clinics, University Medical Centre of Ljubljana, Ljubljana, Slovenia. Electronic address: ksenija.rener@mf.uni-lj.si. 2. Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN, USA. 3. Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, School of Medicine, University of Minnesota, Minneapolis, MN, USA. 4. Department of Biostatistics, Virginia Commonwealth University, Richmond, VA, USA.
Abstract
OBJECTIVE: The aim of this study was to characterize self-reported sleep quality (SQ) in cases with temporomandibular disorder (TMD) and to compare their results with those of healthy controls. METHODS: The Pittsburgh Sleep Quality Index (PSQI) was used to measure SQ in a convenience sample of 609 TMD cases and 88 controls. The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I diagnostic nomenclature was used, but Axis I diagnoses were based on the consensus of two reliable criterion examiners and not the RDC/TMD algorithms. The PSQI scores for TMD cases were calculated also for the RDC/TMD Axis II measures assessing chronic pain and disability, depression, and nonspecific physical symptoms. PSQI scores of the TMD cases were compared with those from controls. RESULTS: TMD cases with one to five TMD diagnoses (n = 609) had a mean PSQI score of 7.0 [95% confidence interval (CI) = 6.7-7.4]. In comparison, the mean score was 5.2 (95% CI = 4.6-5.9) for control subjects. For the subset of TMD cases with pain-free diagnoses (n = 113), the PSQI score was similar to controls with 5.1 (95% CI = 4.5-5.6), whereas it was significantly different for cases with pain-related diagnoses 7.5 (95% CI = 6.6-8.3; n = 87). Although the number of TMD diagnoses and participant age had some influence on SQ, psychosocial status, and pain-related impairment assessed with RDC/TMD Axis II measures had the strongest association with SQ, in particular, dysfunctional chronic pain. CONCLUSION: SQ is impaired in TMD patients with pain-related diagnoses, and even more in those with dysfunctional pain. This relationship between sleep and pain suggests that SQ should be assessed in TMD pain patients, especially in those with significant Axis II involvement.
OBJECTIVE: The aim of this study was to characterize self-reported sleep quality (SQ) in cases with temporomandibular disorder (TMD) and to compare their results with those of healthy controls. METHODS: The Pittsburgh Sleep Quality Index (PSQI) was used to measure SQ in a convenience sample of 609 TMD cases and 88 controls. The Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) Axis I diagnostic nomenclature was used, but Axis I diagnoses were based on the consensus of two reliable criterion examiners and not the RDC/TMD algorithms. The PSQI scores for TMD cases were calculated also for the RDC/TMD Axis II measures assessing chronic pain and disability, depression, and nonspecific physical symptoms. PSQI scores of the TMD cases were compared with those from controls. RESULTS:TMD cases with one to five TMD diagnoses (n = 609) had a mean PSQI score of 7.0 [95% confidence interval (CI) = 6.7-7.4]. In comparison, the mean score was 5.2 (95% CI = 4.6-5.9) for control subjects. For the subset of TMD cases with pain-free diagnoses (n = 113), the PSQI score was similar to controls with 5.1 (95% CI = 4.5-5.6), whereas it was significantly different for cases with pain-related diagnoses 7.5 (95% CI = 6.6-8.3; n = 87). Although the number of TMD diagnoses and participant age had some influence on SQ, psychosocial status, and pain-related impairment assessed with RDC/TMD Axis II measures had the strongest association with SQ, in particular, dysfunctional chronic pain. CONCLUSION: SQ is impaired in TMDpatients with pain-related diagnoses, and even more in those with dysfunctional pain. This relationship between sleep and pain suggests that SQ should be assessed in TMD painpatients, especially in those with significant Axis II involvement.
Authors: Marc Schmitter; Alexandra Kares-Vrincianu; Horst Kares; Justo Lorenzo Bermejo; Hans-Jürgen Schindler Journal: Sleep Med Date: 2015-05-11 Impact factor: 3.492
Authors: Eric L Schiffman; Edmond L Truelove; Richard Ohrbach; Gary C Anderson; Mike T John; Thomas List; John O Look Journal: J Orofac Pain Date: 2010
Authors: Felipe Porto; Reny de Leeuw; Daniel R Evans; Charles R Carlson; Juan F Yepes; Adam Branscum; Jeffrey P Okeson Journal: J Orofac Pain Date: 2011
Authors: Ksenija Rener-Sitar; Mike T John; Dipankar Bandyopadhyay; Michael J Howell; Eric L Schiffman Journal: Health Qual Life Outcomes Date: 2014-01-21 Impact factor: 3.186
Authors: B Dubrovsky; M N Janal; G J Lavigne; D A Sirois; P E Wigren; L Nemelivsky; A C Krieger; K G Raphael Journal: J Oral Rehabil Date: 2017-09-21 Impact factor: 3.837
Authors: Carly A Hunt; Chung Jung Mun; Michael A Owens; Sheera F Lerman; Shriya Kunatharaju; Howard A Tennen; Luis F Buenaver; Claudia M Campbell; Jennifer A Haythornthwaite; Michael T Smith; Patrick H Finan Journal: Psychosom Med Date: 2022-04-01 Impact factor: 4.312
Authors: Kanokporn Bhalang; Beat Steiger; Nenad Lukic; Aleksandra Zumbrunn Wojczyńska; Ray S Hovijitra; Dominik A Ettlin Journal: Front Neurol Date: 2020-12-03 Impact factor: 4.003